Victory Capital Management
ACER

Victory Capital Management’s Acer Therapeutics Inc ACER Stock Holding History

Victory Capital Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,784
Closed -$4K – 3461
2020
Q1 		$4K Buy
+1,784
New +$6.54K ﹤0.01% 3582
2019
Q4 		– Sell
-787
Closed -$3K – 3447
2019
Q3 		$3K Buy
+787
New +$2.31K ﹤0.01% 3593

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management's ACER Position: Q2 2020 in Review

Victory Capital Management sold out of Acer Therapeutics Inc (ACER) in Q2 2020, closing a stake of 1,784 shares — an estimated $4K sold.

Victory Capital Management first reported a position in ACER in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2020. 34 funds tracked by Wall St. Rank hold ACER as of Q2 2020.

  • Victory Capital Management reported no remaining Acer Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,784 Acer Therapeutics Inc shares in Q2 2020, an estimated $4K.
  • Victory Capital Management first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Acer Therapeutics Inc position peaked at $4K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.